Viking Therapeutics (VKTX)

Viking Therapeutics (VKTX) Cash flow


Viking Therapeutics Cash Flow

VKTX's free cash flow for Q1 2024 was $-6.13M. For the 2024 fiscal year, VKTX's free cash flow was decreased by $-24.98M and operating cash flow was $-6.13M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -54.87M$ -73.38M$ -48.40M$ -47.59M$ -21.78M$ -24.75M
Investing Cash Flow
$ -641.08M$ -179.09M$ 54.75M$ 37.96M$ 41.57M$ 7.46M
Financing Cash Flow
$ 873.23M$ 271.38M$ 4.16M$ 6.88M$ 950.00K$ 887.00K
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 358.70M$ 55.52M$ 36.63M$ 26.37M$ 29.12M$ 8.38M
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
-----$ 0.00
Issuance Of Capital Stock
-----$ 0.00
Issuance Of Debt
Repayment Of Debt
-----$ 0.00
Free Cash Flow
$ -35.21M$ -73.38M$ -48.40M$ -47.59M$ -21.78M$ -24.75M
Domestic Sales
Foreign Sales
Currency in USD

Viking Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis